| ISPC 0.1365 17.17% | CTNT 0.0953 -40.73% | BYND 0.8226 5.19% | YXT 0.496 34.05% | TZA 5.08 -6.45% | EFOI 6.49 210.53% | TSLL 13.9 6.35% | NVDA 201.68 1.68% | BITO 10.63 2.71% | NFLX 97.31 -9.72% | INTC 68.5 0.00% | ZSPC 0.0536 -38.46% | TQQQ 58.59 3.83% | SOXS 18.87 -6.95% | TSLA 400.62 3.01% | XLE 55.02 -2.76% | AMC 1.86 15.53% | SCO 8.47 9.72% | PLUG 2.78 -2.80% | BMNG 1.6 4.58% | IBIT 43.94 2.83% | AAL 12.78 4.16% | BZAI 2.52 45.66% | CRML 12.56 35.49% | SOFI 19.43 2.10% | HIVE 2.51 14.87% | GRAB 4.21 4.73% | SPY 710.14 1.21% | SQQQ 56.39 -3.79% | SOXL 94.68 7.14% | SMR 12.65 10.87% | BMNR 22.95 2.27% | SNAP 6.03 0.17% | UCAR 1.49 29.57% | HIMS 28.82 6.78% | LZMH 0.1736 -84.07% | HYG 80.65 0.37% | DRIP 5.25 9.83% | ONDS 10 -1.96% | DVLT 0.758 -9.49% | AAPL 270.23 2.59% | QQQ 648.85 1.31% | MARA 11.6 0.43% | MSTR 166.52 11.80% | AMZN 250.56 0.34% | PLTR 146.39 2.54% | SPDN 9.13 -1.19% | PBM 7.6 29.47% | IONQ 46.09 3.16% | MSFT 422.79 0.60%

Community Health Systems, Inc. (NYSE: CYH) Surpasses Earnings Estimates

Community Health Systems, Inc. (NYSE:CYH) is a prominent player in the healthcare sector, specifically within the Zacks Medical - Hospital industry. The company operates a network of hospitals and healthcare facilities across the United States, providing a range of medical services. CYH competes with other healthcare providers in delivering quality care and maintaining financial stability.

On February 18, 2026, CYH reported its earnings, showcasing an impressive earnings per share (EPS) of $0.80, which significantly exceeded the estimated EPS of -$0.20, reflecting a substantial improvement from the previous year's loss of $0.42 per share. The company has consistently surpassed consensus earnings estimates in three of the last four quarters.

Despite reporting a revenue of approximately $3.106 billion, which was slightly below the estimated $3.137 billion, CYH's financial performance remains noteworthy. The revenue for the quarter ending December 2025 fell short of the Zacks Consensus Estimate by 1.18%, yet the company has exceeded consensus revenue estimates three times in the last four quarters. This indicates a strong track record of financial performance.

CYH's financial health is further demonstrated by its net income attributable to stockholders, which reached $110 million, translating to $0.81 per diluted share. This marks a significant turnaround from the previous period's net loss of $70 million. The company's price-to-earnings (P/E) ratio of approximately 0.88 and price-to-sales ratio of about 0.037 suggest a relatively low valuation compared to its earnings and sales.

The company's liquidity position is solid, with a current ratio of about 1.46, indicating its ability to cover short-term obligations. However, the debt-to-equity ratio is negative at approximately -0.79, showing more liabilities than equity. Despite this, CYH's enterprise value to sales ratio of around 0.069 and enterprise value to operating cash flow ratio of approximately 1.59 reflect a reasonable valuation in relation to its sales and cash flow.

Published on: February 19, 2026